Cro Pharmatrendz Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.06 Cr
- Satisfied Charges ₹ 2.00 M
- Revenue Growth 12.99%
- Profit Growth 18.28%
- Ebitda 104.27%
- Net Worth 32.76%
- Total Assets 56.77%
About Cro Pharmatrendz
Cro Pharmatrendz Private Limited (CPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 06 June 2017 (Seven years and eight months 0 days old ). Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.06 Cr. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U93000OR2017PTC027165
-
Company No.
027165
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Jun 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Cro Pharmatrendz?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minati Patra
|
Director | 04-Nov-2020 | Current |
|
Saiprasanna Behera
|
Director | 06-Jun-2017 | Current |
Financial Performance of Cro Pharmatrendz.
Cro Pharmatrendz Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.99% increase. The company also saw a substantial improvement in profitability, with a 18.28% increase in profit. The company's net worth Soared by an impressive increase of 32.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cro Pharmatrendz?
In 2023, Cro Pharmatrendz had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.64 M
₹2.00 M
Charges Breakdown by Lending Institutions
- Tata Capital Financial Services Limited : 0.71 Cr
- Others : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2024 | Others | ₹3.50 M | Open |
| 31 Oct 2023 | Tata Capital Financial Services Limited | ₹7.14 M | Open |
| 02 Jun 2022 | Hdfc Bank Limited | ₹2.00 M | Satisfied |
How Many Employees Work at Cro Pharmatrendz?
Unlock and access historical data on people associated with Cro Pharmatrendz, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cro Pharmatrendz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cro Pharmatrendz's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
